Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation
Open Access
- 1 September 2020
- journal article
- research article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 8 (17) , 1067
Abstract
Background: Liver transplantation (LT) is an effective option for hepatocellular carcinoma (HCC) and end-stage liver cirrhosis. However, organ shortage and tumor recurrence are the main obstacles limiting its popularization and application in HCC patients. Testing for circulating tumor cells (CTCs) would be a valuable strategy to predict the recurrence and metastasis of HCC after LT. Various CTCs detection methods have different advantages and disadvantages. This study aims to investigate the predictive value of testing for CTCs based on immunofluorescence in situ hybridization of peripheral blood cells in patients with HCC after LT. Methods: A total of 50 patients who received testing for CTCs and then underwent LT were enrolled in this study. Negative enrichment and immunofluorescence in situ hybridization (imFISH) methods were introduced to detect CTCs. Results: Twenty-six (52%) patients were CTC-positive, and 24 (48%) patients were CTC-negative. The results showed that CTCs result was correlated with tumor size (ꭓ2=5.773, P=0.016), AFP level (ꭓ2=5.454, P=0.020), tumor grade (ꭓ2=6.478, P=0.039) and Recurrence(ꭓ2=6.211, P=0.013).Twelve patients had recurrence after LT within one year. The results showed that the CTCs result (P=0.034) was the only independent factor impacting long-term survival. The 1-year disease-free survival rates of CTC-negative and CTC-positive patients were 91.6% and 61.5%, respectively (P=0.020). The 1-year overall survival of CTC-positive patients and CTC-negative was 88.5% and 91.7%, respectively (P=0.751). Conclusions: CTCs result was closely related to the early recurrence of patients with HCC after LT. CTC-positive patients had a worse prognosis after LT than the CTC-negative group.Keywords
This publication has 30 references indexed in Scilit:
- Liver transplantation for hepatocellular carcinomaCurrent Opinion in Organ Transplantation, 2017
- OPTN/SRTR 2015 Annual Data Report: LiverAmerican Journal of Transplantation, 2017
- Treatment of hepatocellular carcinoma: beyond international guidelinesLiver International, 2016
- Flexible Micro Spring Array Device for High-Throughput Enrichment of Viable Circulating Tumor CellsClinical Chemistry, 2014
- Circulating stem cell–like epithelial cell adhesion molecule–positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resectionHepatology, 2012
- Some New Approaches to the Management of Hepatocellular CarcinomaSeminars in Oncology, 2012
- Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinomaJournal of Hepatology, 2012
- Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma (Br J Surg 2007; 94: 96–105)British Journal of Surgery, 2007
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996